Skip Navigation National Cancer Institute U.S. National Institutes of Health www.cancer.gov
 
OverviewCurrent NCI HIV/AIDS Research ActivitiesAccomplishments of NCI Scientists

Current NCI HIV/AIDS Research Activities

Dr. Eric Freed is part of the HIV Drug Resistance Program, an NCI initiative addressing the challenge of developing HIV therapeutics that are effective against drug-resistant virus.

The NCI conducts and supports research in HIV/AIDS and HIV malignancy throughout many of its Divisions, Centers, and Offices. As part of its role in overseeing research efforts in this field, some research activities are directly supported by the Office of HIV and AIDS Malignancy (OHAM).

An active research program in HIV/AIDS and HIV malignancies is conducted by scientists working at the NCI campuses in Bethesda, Rockville, and Frederick, Maryland. The Center of Excellence in HIV/AIDS and Cancer Virology coordinates scientists working throughout a number of Programs and Branches, including the:

In addition, a broad range of extramural HIV/AIDS research, mostly focused on HIV malignancies, is supported by the NCI. Some of the Divisions, Centers, and Offices with robust HIV/AIDS research programs include the:

Yuan Chang, M.D. and Patrick Moore, M.D., MPH co-discovered Kaposiís sarcoma-associated herpesvirus (KSHV)óthe cause of the AIDS-defining cancer, Kaposiís sarcoma.